Pluri Chairman and Active Investor Alejandro Weinstein to Acquire EIB Loan, in Strong Vote of Confidence in the Company

Chairman-led transaction marks the first step in a broader series of actions to provide a more flexible framework to support the Company's commercial plansHAIFA, Israel, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq, TASE: PLUR) (“Pluri” or the “Company”), a biotechnology company advancing cell-based solutions in regenerative medicine and longevity, today announced that Alejandro Weinstein, Chairman of the Board and the largest shareholder of the Company, has entered into an agreement to